We are pleased to announce that our N-NOSE has been introduced as part of Sojitz Corporation’s efforts to maintain and promote health for its employees.
A location for the submission of N-NOSE specimens has been established at the Sojitz Corporation’s Tokyo Head Office/Kansai Branch Clinic.
We will continue to provide the N-NOSE for early detection of cancer and to support corporate health management as well as to contribute to raising health awareness throughout society.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29